Unraveling behavioral deficits in neurofibromatosis type 1: Insights from Drosophila and mouse models
Eirini Georganta, Kalliopi Atsoniou, Kyriaki Foka, Panagiotis Giannousas, Ourania Semelidou, Efthimios M.C. Skoulakis · FENS Forum 2024
Neurofibromatosis type 1 (NF1) is a monogenic but highly multisymptomatic disorder that affects 1:2500 individuals and results from mutations in the Nf1 tumor suppressor gene. Nf1 encodes Neurofibromin (Nf1), a large multifunctional protein, preferentially expressed in the central and peripheral nervous system, crucial for regulating multiple signaling pathways. Although typically considered a tumor predisposition syndrome, NF1 is also associated with broad cognitive and behavioral presentations, including impaired learning, attention deficit hyperactivity disorder, autism spectrum disorder, s
ePoster · Neuroscience